Literature DB >> 20567644

Dissociative anesthesia in an office-based plastic surgery practice.

Charles A Vinnik1.   

Abstract

In 1974, the author began to use ketamine in association with diazepam for cosmetic and reconstructive procedures. Since then, through courses in the United States and abroad, well over a thousand plastic surgeons have been taught the technique. Ketamine, by itself, ablates sensory input of pain at the thalamic level but has been associated with hallucinations, bad dreams, and other untoward effects. These can be prevented by the use of benzodiazepines, which "bracket" the use of ketamine. If the patient is sedated and awakens under the influence of these agents, there is no adverse ketamine effect. Specific techniques and adjunct agents are described.

Entities:  

Keywords:  Ketamine; Robinul®; Valium®; Versed®; dissociative anesthesia; fentanyl; midazolam

Year:  2007        PMID: 20567644      PMCID: PMC2884819          DOI: 10.1055/s-2007-979211

Source DB:  PubMed          Journal:  Semin Plast Surg        ISSN: 1535-2188            Impact factor:   2.314


  5 in total

1.  The effect of a dissociative dose of ketamine on the bispectral index (BIS) during propofol hypnosis.

Authors:  B L Friedberg
Journal:  J Clin Anesth       Date:  1999-02       Impact factor: 9.452

2.  Is there a place for the use of ketamine in plastic and reconstructive surgery?

Authors:  E Gallozzi
Journal:  Ann Plast Surg       Date:  1980-01       Impact factor: 1.539

3.  An intravenous dissociation technique for outpatient plastic surgery: tranquility in the office surgical facility.

Authors:  C A Vinnik
Journal:  Plast Reconstr Surg       Date:  1981-06       Impact factor: 4.730

4.  Propofol-ketamine technique.

Authors:  B L Friedberg
Journal:  Aesthetic Plast Surg       Date:  1993       Impact factor: 2.326

5.  Diazepam-ketamine anaesthesia for open heart surgery "micro-mini" drip administration technique.

Authors:  S Hatano; M S Sadove; D M Keane; R E Boggs; M A El-Naggar
Journal:  Anaesthesist       Date:  1976-10       Impact factor: 1.041

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.